1Xu TH, Ding J, Shi YL, et al. Effects of myasthenia gravis patients' sera with different autoantibodies on slow K^+ current at mouse motor nerve terminals. Neurol Res, 2003, 25: 58-62.
2Vincent A, McConville J, Farrugia ME, et al. Antibodies in myasthenia gravis and related disorders. Ann N Y Acad Sci, 2003,998:324-335.
3Evoli A, Tonali PA, Padua L, et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.Brain, 2003,126:2304-2311.
4McConville J, Farrugia ME, Beeson D, et al. Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol, 2004,55:580-584.
5Scott BG, Yang H, Tuzun E, et al. ICOS is essential for the development of experimental autoimmune myasthenia gravis. J Neuroimmunol, 2004.153 : 16-25.
6Balandina A, Lecart S, Dartevelle P, et al. Functional defect of regulatory CD4^+CD25^+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood, 2005,105:735-741.
7Maiti PK, Im SH, Souroujon MC, et al. A monoclonal antibody specific for rat IL-18BP and its application in determining serum IL-18BP. Immunol Lett, 2003,85:65-70.
8Poussin MA, Fuller CL, Goluszko E, et al. Suppressed clinical experimental autoimmune myasthenia gravis in bml2 mice is linked to reduced intracellular calcium mobilization and IL-10 and IFN-gamma release by acetylcholine receptor-specific T cells. J Neuroimmunol, 2003,134 : 104-110.
9Zhao X, Gharizadeh B, Hjelmstrom P, et al. Genotypes of CCR2 and CCR5 chemokine receptors in human myasthenia gravis. Int J Mol Med, 2003,12:749-753.
10Vandiedonck C, Beaurain G, Giraud M, et al. Pleiotropic effects of the 8. 1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia. Proc Natl Acad Sci U S A, 2004,101:15464-15469.
6Kalamida D, Poulas K, Avramopoulou V, et al. Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity[J]. FEBS J,2007,274(15) :3799.
7Dellisanti CD, Yao Y, Stroud JC, et al. Crystal structure of the extracellular domain of nAChR alphal bound to alpha - bungarotoxin at 1.94 A resolution[J]. Nat Neurosci,2007,10(8) :953.
8Kozak M. An analysis of 5' - noncoding sequences from 699 vertebrate messenger RNAs[J]. Nucleic Acids Res, 1987, 15 (20) : 8125 - 8148.
9Li ZY, Li YJ, Guo CY, et al. Soluble expression and affinity purification of functional domain of human acetylcholine receptor α- subunit by the modulation of maltose binding protein[J]. Biotech Nology Letters, 2004,26(23) : 1765 - 1769.
10Wells GB. Structural answers and persistent questions about how nicotinic receptors work [J]. Front Biosci, 2008,13 ( 5 ) : 5479 - 5510.
